For the primary endpoint, the relative risk reduction in the mITT1 analysis population for PAXLOVID compared to placebo was 86% (95% CI: 72%, 93%)
Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma
If it's supplemental
Hospira Bacteriostatic Water Canada is a Pfizer/Hospira 30mL multi-dose vial containing sterile water with 0.9% benzyl alcohol as a preservative
Pozzo-Miller (2003)
Water, Butylene Glycol, Glycerin, Niacinamide, 1,2-Hexanediol, Isopentyldiol, Trehalose, Carbomer, Arginine, Allantoin, Panthenol, Ethylhexylglycerin, Polyglyceryl-10 Laurate, Xanthan Gum, Adenosine, Melia Azadirachta (Neem) Leaf Extract, Melia Azadirachta Flower Extract, Disodium EDTA, Glyceryl Acrylate/Acrylic Acid Copolymer, Sodium DNA (PDRN), Coccinia Indica Fruit Extract, Solanum Melongena (Eggplant) Fruit Extract, Ocimum Sanctum Leaf Extract, Propanediol, Curcuma Longa (Turmeric) Root Extract, Corallina Officinalis Extract, Hydrolyzed Hyaluronic Acid, Glyceryl Oleate, Lauryl Glucoside, Myristyl Glucoside, Polyglyceryl-6 Laurate, Hydrogenated Lecithin, Hydrolyzed Collagen, Sodium Hyaluronate, Coptis Japonica Root Extract, Glutathione, Hyaluronic Acid, Hydrolyzed Sodium Hyaluronate, Hydroxypropyltrimonium Hyaluronate, Potassium Hyaluronate, Sodium Hyaluronate Crosspolymer, Citric Acid, Sodium Citrate, Pentylene Glycol, Sodium Acetylated Hyaluronate
